Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis

Am J Obstet Gynecol. 2008 Dec;199(6):620.e1-8. doi: 10.1016/j.ajog.2008.07.008. Epub 2008 Oct 30.

Abstract

Objective: We conducted a metaanalysis to determine whether antibiotics prolong pregnancy and reduce neonatal morbidity in preterm premature rupture of membranes (PPROM) and preterm labor (PTL) at 34 weeks or less.

Study design: Randomized trials comparing antibiotic therapy with placebo in PPROM or PTL at a gestation of 34 weeks or less were retrieved. The primary outcome was time to delivery (latency). Infant outcomes included mortality, infection, neurological abnormality, respiratory disease, and neonatal stay.

Results: Antibiotics were associated with prolongation of pregnancy in PPROM (P < .01) but not PTL. Clinically diagnosed neonatal infections were reduced in both groups; there was a trend toward reduced culture-positive sepsis in PPROM. Intraventricular hemorrhage (all grades) was reduced in PPROM. Other neonatal outcomes were unaffected by antenatal antibiotics.

Conclusion: Antibiotics prolong pregnancy and reduce neonatal morbidity in women with PPROM at a gestation of 34 weeks or less. In PTL at a gestation of 34 weeks or less, there is little evidence of benefit from administration of antibiotics.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Fetal Membranes, Premature Rupture / drug therapy*
  • Fetal Membranes, Premature Rupture / prevention & control
  • Follow-Up Studies
  • Humans
  • Infant Mortality / trends
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / prevention & control*
  • Obstetric Labor, Premature / drug therapy*
  • Obstetric Labor, Premature / prevention & control
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy Trimester, Third
  • Probability
  • Randomized Controlled Trials as Topic
  • Reference Values
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Bacterial Agents